☰

Gerardo Machnicki, Ph.D. - Publications

Affiliations: 
2010 Public Health Studies Saint Louis University, St. Louis, MO, United States 
Area:
Public Health, Health Care Management
Tree Info Similar researchers PubMed Report error

25 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Hungria V, Martínez-Baños DM, Mateos MV, Dimopoulos MA, Cavo M, Heeg B, Garcia A, Lam A, Machnicki G, He J, Fernandez M. Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Standard of Care in Latin America for Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Propensity Score Matching Analysis. Advances in Therapy. PMID 33067698 DOI: 10.1007/s12325-020-01521-9  0.351
2019 Hungria VT, Martinez-Banos DM, Mateos M, Dimopoulos MA, Cavo M, Heeg B, Lam A, Machnicki G, He J, Fernandez M. Comparison of Daratumumab Plus Bortezomib, Melphalan, and Prednisone (D-VMP) with Standard of Care for Patients from Latin America with Newly Diagnosed Multiple Myeloma (NDMM) Who Were Transplant Ineligible: A Propensity Score Matching Analysis Blood. 134: 2143-2143. DOI: 10.1182/blood-2019-123557  0.313
2011 Machnicki G, Lentine KL, Salvalaggio PR, Burroughs TE, Brennan DC, Schnitzler MA. Kidney transplant Medicare payments and length of stay: associations with comorbidities and organ quality. Archives of Medical Science : Ams. 7: 278-86. PMID 22291768 DOI: 10.5114/Aoms.2011.22079  0.753
2011 Woodward RS, Flore MC, Machnicki G, Brennan DC. The long-term outcomes and costs of diabetes mellitus among renal transplant recipients: tacrolimus versus cyclosporine. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 14: 443-9. PMID 21315636 DOI: 10.1016/j.jval.2010.10.030  0.597
2011 Machnicki G, Lentine KL, Salvalaggio PR, Burroughs TE, Brennan DC, Schniztler MA. Three-year post-transplant Medicare payments in kidney transplant recipients: associations with pre-transplant comorbidities. Saudi Journal of Kidney Diseases and Transplantation : An Official Publication of the Saudi Center For Organ Transplantation, Saudi Arabia. 22: 24-39. PMID 21196610  0.726
2010 Lentine KL, Xiao H, Machnicki G, Gheorghian A, Schnitzler MA. Renal function and healthcare costs in patients with polycystic kidney disease. Clinical Journal of the American Society of Nephrology : Cjasn. 5: 1471-9. PMID 20538839 DOI: 10.2215/Cjn.00780110  0.618
2009 Dmitrienko S, Balshaw R, Machnicki G, Shapiro RJ, Keown PA. Probabilistic modeling of cytomegalovirus infection under consensus clinical management guidelines. Transplantation. 87: 570-7. PMID 19307796 DOI: 10.1097/Tp.0B013E3181949E09  0.446
2009 Machnicki G, Pinsky B, Takemoto S, Balshaw R, Salvalaggio PR, Buchanan PM, Irish W, Bunnapradist S, Lentine KL, Burroughs TE, Brennan DC, Schnitzler MA. Predictive ability of pretransplant comorbidities to predict long-term graft loss and death. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 9: 494-505. PMID 19120083 DOI: 10.1111/J.1600-6143.2008.02486.X  0.701
2008 Machnicki G, Ricci JF, Brennan DC, Schnitzler MA. Economic impact and long-term graft outcomes of mycophenolate mofetil dosage modifications following gastrointestinal complications in renal transplant recipients. Pharmacoeconomics. 26: 951-67. PMID 18850764 DOI: 10.2165/00019053-200826110-00007  0.686
2008 Machnicki G, Pefaur J, Gaite L, Linchenco AM, Raimondi C, Schiavelli R, Otero A, Margolis MK. Gastrointestinal (GI)-Specific patient reported outcomes instruments differentiate between renal transplant patients with or without GI symptoms: results from a South American cohort. Health and Quality of Life Outcomes. 6: 53. PMID 18644133 DOI: 10.1186/1477-7525-6-53  0.428
2008 Neri L, Rocca Rey LA, Pinsky BW, Lentine KL, Salvalaggio PR, Machnicki G, Willoughby L, Burroughs TE, Takemoto SK, Schnitzler MA. Increased risk of graft failure in kidney transplant recipients after a diagnosis of dyspepsia or gastroesophageal reflux disease. Transplantation. 85: 344-52. PMID 18301330 DOI: 10.1097/Tp.0B013E318160D4C4  0.756
2008 Lehmkuhl H, Arizon J, Almenar L, Magelli C, Gerosa G, Varnous S, Musumeci F, Mattei M-, Vanhaecke J, Mange K, Machnicki G, Livi U. DECREASE OF MAJOR CARDIAC EVENTS AND HOSPITALIZATIONS IN DE NOVO HEART TRANSPLANT RECIPIENTS RECEIVING EVEROLIMUS: RESULTS FROM A 12-MONTH, MULTICENTER, RANDOMIZED TRIAL COMPARING EVEROLIMUS WITH MMF Transplantation. 86: 240. DOI: 10.1097/01.tp.0000332064.44238.d2  0.38
2008 Lehmkuhl H, Arizon J, Almenar L, Magelli C, Gerosa G, Varnous S, Musumeci F, Mattei M, Vanhaecke J, Mange K, Machnicki G. 466: Hospitalization Days Due to Major Cardiac Events (MACE) in De Novo Heart Transplant Recipients: Data from a 12-Month, Multicenter, Randomized Trial of Everolimus Versus MMF The Journal of Heart and Lung Transplantation. 27: S228. DOI: 10.1016/j.healun.2007.11.479  0.37
2007 Burroughs TE, Lentine KL, Takemoto SK, Swindle J, Machnicki G, Hardinger K, Brennan DC, Irish WD, Schnitzler MA. Influence of early posttransplantation prednisone and calcineurin inhibitor dosages on the incidence of new-onset diabetes. Clinical Journal of the American Society of Nephrology : Cjasn. 2: 517-23. PMID 17699459 DOI: 10.2215/Cjn.00620206  0.718
2007 Burroughs TE, Swindle J, Takemoto S, Lentine KL, Machnicki G, Irish WD, Brennan DC, Schnitzler MA. Diabetic complications associated with new-onset diabetes mellitus in renal transplant recipients. Transplantation. 83: 1027-34. PMID 17452891 DOI: 10.1097/01.Tp.0000259617.21741.95  0.704
2006 Kleinman L, Kilburg A, Machnicki G, Faull R, Walker R, Prasad R, Ambuehl P, Bahner U, Margolis MK. Using GI-specific patient outcome measures in renal transplant patients: validation of the GSRS and GIQLI. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 15: 1223-32. PMID 16972162 DOI: 10.1007/s11136-006-0053-5  0.477
2006 Schnitzler M, Machnicki G. ABO-incompatible living donor transplantation: is it economically "compatible"? Transplantation. 82: 168-9. PMID 16858277 DOI: 10.1097/01.Tp.0000226242.10027.E7  0.707
2006 Helderman J, Gilmore A, Ryskina K, Legorreta A, Naujoks C, Machnicki G. PUK4 AN ECONOMIC EVALUATION OF DE NOVO RENAL TRANSPLANT RECIPIENTS USING BRANDED (B-CSA) VS. NON-BRANDED CYCLOSPORINE MODIFIED (NB-CSA) Value in Health. 9: A385. DOI: 10.1016/S1098-3015(10)63771-0  0.545
2006 Legorreta A, Kang N, Gilmore A, Marehbian J, Naujoks C, Machnicki G. PCV19 DISCONTINUED USE OF MYCOPHENOLATE MOFETIL AND GRAFT LOSS IN HEART TRANSPLANT RECIPIENTS Value in Health. 9: A342. DOI: 10.1016/S1098-3015(10)63635-2  0.517
2006 Machnicki G, Seriai L, Schnitzler MA. Economics of transplantation: a review of the literature Transplantation Reviews. 20: 61-75. DOI: 10.1016/J.Trre.2006.05.001  0.67
2005 Machnicki G, Pinsky B, Takemoto S, Lentine K, Willoughby L, Bunnapradist S, Burroughs T, Schnitzler MA. Application of diagnostic classification algorithms to identify the most common causes of post-transplant complications. Clinical Transplants. 57-67. PMID 17424725  0.69
2005 Balshaw R, Machnicki G, Carreño CA, Toselli L, Otero A, Keown PA. Two-hour post-dose cyclosporine levels in renal transplantation in Argentina: a cost-effective strategy for reducing acute rejection. Transplantation Proceedings. 37: 871-4. PMID 15848560 DOI: 10.1097/00007890-200407271-01377  0.457
2004 Balshaw R, Keown P, Budde K, Machnicki G, Kalo Z. FTY720 VS. MYCOPHENOLATE MOFETIL, ECONOMIC IMPACT IN CYCLOSPORINE BASED IMMUNOSUPRESSION FOR DE NOVO RENAL TRANSPLANTATION Transplantation. 78: 511. DOI: 10.1097/00007890-200407271-01378  0.612
2004 Brennan DC, Kutinova A, Machnicki G, Woodward RS. THE INCIDENCE AND COSTS OF HEPATITIS BEFORE AND AFTER RENAL TRANSPLANTATION Transplantation. 78: 481. DOI: 10.1097/00007890-200407271-01294  0.511
2004 Kleinman L, Bahner U, Faull R, Walker R, Prasad R, Ambuehl P, Machnicki G, Margolis M. PGI11 PSYCHOMETRIC VALIDATION OF TWO GASTROINTESTINAL (GI)-SPECIFIC PATIENT-REPORTED OUTCOME (PRO) INSTRUMENTS IN RENAL TRANSPLANT PATIENTS WITH AND WITHOUT GI COMPLICATIONS Value in Health. 7: 756-757. DOI: 10.1016/S1098-3015(10)66014-7  0.478
Show low-probability matches.